Rates

RAW Capital Partners has reduced the rates on its two most popular products for non-UK residents and UK expats.

Our introductory fixed rate has been reduced from 6.99% to 6.49% for a limited time only. The variable rate product is now priced at an interest rate margin of 2.25% above Bank Rate.

The 6.49% introductory fixed rate is available for UK expats and non-UK residents so long as they complete before 31 October 2024. The BTL asset must be located in a major UK town or city. With more than £100 million of capital available to lend, RAW is offering its new, lower rates on the first 55% LTV of its term loan products.

Brokers and borrowers will continue to benefit from RAW’s fast and flexible service with all circumstances considered and decisions in principle typically delivered within 24 hours.

Ben Nichols, Interim Managing Director of RAW Capital Partners, said: “As the company continues to grow, we’re seeing increased demand from brokers working with international clients - a group that often struggles to find support from other lenders. We’re working tirelessly to ensure our products and service meet the needs of brokers and borrowers, and lowering our fixed rates is another example of that.

“Appetite for UK residential property remains strong among international investors, so our focus is on ensuring they are well served from a finance perspective. We’re looking forward to working with existing and new intermediaries as we enter the second half of the year.”

RAW Capital Partners, through its RAW Mortgage Fund, provides specialist buy-to-let (BTL) mortgages to a global client-base investing in UK properties. The company has doubled in size in 2023 - now employing over 45 members of staff in Guernsey, Southampton, and London. 

The RAW Mortgage Fund has grown via private investment from individuals and institutions. RAW Capital Partners offers investors attractive returns, a high level of capital security, and total fee transparency through the Fund, which has a nine-year track record of consistent returns up to 8.57%* per year (based on A class shares).